Over the past 12 months, 5 insiders at Outset Medical, Inc. filed 21 open-market SEC Form 4 transactions on OM: 0 purchases worth $0 and 21 sales worth $324K. Insiders have been net sellers over this period. The most recent filing was on Jun 3, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 3, 26 | Renee GaetaChief Financial Officer | SELL | 17.7K | $4.94 | $87K |
| May 15, 26 | John L. BrottemGeneral Counsel | SELL | 2.6K | $3.70 | $10K |
| Feb 17, 26 | John L. BrottemGeneral Counsel | SELL | 2.8K | $3.35 | $10K |
| Feb 17, 26 | Marc NashEVP Operations R&D & Service | SELL | 1.8K | $3.35 | $6K |
| Feb 17, 26 | Leslie TriggChair and CEO | SELL | 3.4K | $3.35 | $11K |
| Jan 21, 26 | John L. BrottemGeneral Counsel | SELL | 1.2K | $5.01 | $6K |
| Jan 21, 26 | Marc NashEVP Operations R&D & Service | SELL | 980 | $4.98 | $5K |
| Jan 21, 26 | Leslie TriggChair and CEO | SELL | 2.1K | $5.05 | $11K |
| Jan 20, 26 | John L. BrottemGeneral Counsel | SELL | 9.3K | $5.12 | $48K |
| Jan 20, 26 | Marc NashEVP Operations R&D & Service | SELL | 5.4K | $5.12 | $28K |
| Jan 20, 26 | Leslie TriggChair and CEO | SELL | 11.8K | $5.12 | $60K |
| Jan 7, 26 | John L. BrottemGeneral Counsel | SELL | 224 | $4.27 | $956 |
| Jan 7, 26 | Marc NashEVP Operations R&D & Service | SELL | 108 | $4.27 | $461 |
| Jan 7, 26 | Leslie TriggChair and CEO | SELL | 1.8K | $4.27 | $8K |
| Dec 1, 25 | Karen DrexlerDirector | SELL | 1.5K | $4.37 | $7K |
| Nov 17, 25 | John L. BrottemGeneral Counsel | SELL | 388 | $4.60 | $2K |
| Nov 17, 25 | Marc NashEVP Operations R&D & Service | SELL | 247 | $4.60 | $1K |
| Nov 17, 25 | Leslie TriggChair and CEO | SELL | 916 | $4.60 | $4K |
| Aug 15, 25 | John L. BrottemGeneral Counsel | SELL | 383 | $12.88 | $5K |
| Aug 15, 25 | Marc NashSVP Operations and R&D | SELL | 243 | $12.88 | $3K |
| Aug 15, 25 | Leslie TriggChair and CEO | SELL | 904 | $12.88 | $12K |
| May 15, 25 | Nabeel AhmedChief Financial Officer | SELL | 584 | $17.81 | $10K |
| May 15, 25 | John L. BrottemGeneral Counsel | SELL | 396 | $17.82 | $7K |
| May 15, 25 | Marc NashSVP Operations and R&D | SELL | 252 | $17.82 | $4K |
| May 15, 25 | Leslie TriggChair and CEO | SELL | 935 | $17.80 | $17K |
| Feb 18, 25 | Nabeel AhmedChief Financial Officer | SELL | 8.7K | $0.90 | $8K |
| Feb 18, 25 | John L. BrottemGeneral Counsel | SELL | 6.1K | $0.90 | $6K |
| Feb 18, 25 | Marc NashSVP Operations and R&D | SELL | 4.2K | $0.90 | $4K |
| Feb 18, 25 | Leslie TriggChair and CEO | SELL | 14.6K | $0.90 | $13K |
| Jan 21, 25 | Nabeel AhmedChief Financial Officer | SELL | 29.5K | $0.80 | $24K |
| Jan 21, 25 | John L. BrottemGeneral Counsel | SELL | 29.5K | $0.80 | $24K |
| Jan 21, 25 | Marc NashSVP Operations and R&D | SELL | 21.6K | $0.80 | $17K |
| Jan 21, 25 | Leslie TriggChair and CEO | SELL | 42.4K | $0.80 | $34K |
| Jan 13, 25 | Nabeel AhmedChief Financial Officer | SELL | 29.0K | $0.81 | $24K |
| Jan 13, 25 | John L. BrottemGeneral Counsel | SELL | 20.5K | $0.81 | $17K |
| Jan 13, 25 | Marc NashSVP Operations and R&D | SELL | 15.0K | $0.81 | $12K |
| Jan 13, 25 | Leslie TriggChair and CEO | SELL | 33.2K | $0.81 | $27K |
| Jan 7, 25 | Nabeel AhmedChief Financial Officer | SELL | 1.8K | $1.29 | $2K |
| Jan 7, 25 | John L. BrottemGeneral Counsel | SELL | 1.6K | $1.29 | $2K |
| Jan 7, 25 | Marc NashSVP Operations and R&D | SELL | 720 | $1.29 | $929 |
| Jan 7, 25 | Leslie TriggChair and CEO | SELL | 10.2K | $1.29 | $13K |
| Nov 15, 24 | Nabeel AhmedChief Financial Officer | SELL | 4.2K | $0.80 | $3K |
| Nov 15, 24 | John L. BrottemGeneral Counsel | SELL | 3.2K | $0.80 | $3K |
| Nov 15, 24 | Marc NashSVP Operations and R&D | SELL | 1.4K | $0.80 | $1K |
| Nov 15, 24 | Leslie TriggChair and CEO | SELL | 5.6K | $0.80 | $5K |
| Aug 15, 24 | Nabeel AhmedChief Financial Officer | SELL | 4.0K | $0.84 | $3K |
| Aug 15, 24 | John L. BrottemGeneral Counsel | SELL | 3.0K | $0.84 | $3K |
| Aug 15, 24 | Marc NashSVP Operations and R&D | SELL | 1.3K | $0.84 | $1K |
| Aug 15, 24 | Leslie TriggChair and CEO | SELL | 5.3K | $0.84 | $4K |
| Jul 24, 24 | Marc NashSVP Operations and R&D | SELL | 723 | $4.02 | $3K |
Over the past 12 months, insiders at Outset Medical, Inc. filed 0 open-market purchases worth $0 and 21 sales worth $324K on OM, which makes them net sellers over the period. The most recent Form 4 was filed on Jun 3, 26.
5 different insiders at Outset Medical, Inc. filed open-market SEC Form 4 transactions on OM over the last 12 months.
InsiderTape plots every OM insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Outset Medical, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →